Effects of separate and combined estradiol and progesterone administration on fear extinction in healthy pre-menopausal women.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
24 Oct 2024
Historique:
received: 22 12 2023
accepted: 28 08 2024
revised: 21 08 2024
medline: 25 10 2024
pubmed: 25 10 2024
entrez: 25 10 2024
Statut: epublish

Résumé

Altered fear conditioning and extinction learning are discussed as key etiological features in anxiety disorders. Women have an increased risk for anxiety disorders and fear conditioning has been shown to be influenced by the menstrual cycle phase and circulating gonadal hormones. The objective of our study was to investigate the effects of separate and combined estradiol and progesterone administration on fear extinction in healthy women. We conducted a placebo-controlled, randomized study in healthy women, who completed a fear conditioning paradigm on three consecutive days: fear acquisition training on day 1, fear extinction training on day 2, and return of fear test on day 3. Skin conductance responses (SCRs) served as main outcome variable. Two hours before testing on day 2, participants received pills containing either placebo, estradiol (2 mg), progesterone (400 mg) or the combination of both. We examined 116 women (mean age 25.7 ± 6.0 years), who showed significantly stronger conditioned SCRs to the CS+ than CS- during fear acquisition training indicating successful fear learning. At the beginning of the fear extinction training, estradiol administration reduced the differentiation between the conditioned stimuli. In the return of fear test, the estradiol groups showed heightened SCR responses to the previously extinguished stimulus, i.e., impaired extinction recall. Administration of progesterone did not have any significant influence on SCRs. There were also no effects on fear potentiated startle response. In our interpretation, exogenous estradiol administration affected the extinction of the conditioned fear response which led subsequently to a stronger return of fear. From a clinical perspective our findings suggest that estradiol levels may have an influence on the success of exposure therapy and could be taken into consideration when planning exposure sessions.

Identifiants

pubmed: 39448569
doi: 10.1038/s41398-024-03079-4
pii: 10.1038/s41398-024-03079-4
doi:

Substances chimiques

Progesterone 4G7DS2Q64Y
Estradiol 4TI98Z838E

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

449

Informations de copyright

© 2024. The Author(s).

Références

Lonsdorf TB, Menz MM, Andreatta M, Fullana MA, Golkar A, Haaker J, et al. Don’t fear ‘fear conditioning’: methodological considerations for the design and analysis of studies on human fear acquisition, extinction, and return of fear. Neurosci Biobehav Rev. 2017;77:247–85.
doi: 10.1016/j.neubiorev.2017.02.026 pubmed: 28263758
Duits P, Cath DC, Lissek S, Hox JJ, Hamm AO, Engelhard IM, et al. Updated meta-analysis of classical fear conditioning in the anxiety disorders. Depress Anxiety. 2015;32:239–53.
doi: 10.1002/da.22353 pubmed: 25703487
Li SH, Graham BM. Why are women so vulnerable to anxiety, trauma-related and stress-related disorders? The potential role of sex hormones. Lancet Psychiatry. 2017;4:73–82.
Cover KK, Maeng LY, Lebrón-Milad K, Milad MR. Mechanisms of estradiol in fear circuitry: implications for sex differences in psychopathology. Transl Psychiatry. 2014;4:e422.
doi: 10.1038/tp.2014.67 pubmed: 25093600 pmcid: 4150242
Garcia NM, Walker RS, Zoellner LA. Estrogen, progesterone, and the menstrual cycle: a systematic review of fear learning, intrusive memories, and PTSD. Clin Psychol Rev. 2018;66:80–96.
doi: 10.1016/j.cpr.2018.06.005 pubmed: 29945741
Gupta RR, Sen S, Diepenhorst LL, Rudick CN, Maren S. Estrogen modulates sexually dimorphic contextual fear conditioning and hippocampal long-term potentiation (LTP) in rats(1). Brain Res. 2001;888:356–65.
doi: 10.1016/S0006-8993(00)03116-4 pubmed: 11150498
Markus EJ, Zecevic M. Sex differences and estrous cycle changes in hippocampus-dependent fear conditioning. Psychobiology. 1997;25:246–52.
doi: 10.3758/BF03331934
Blair RS, Acca GM, Tsao B, Stevens N, Maren S, Nagaya N. Estrous cycle contributes to state-dependent contextual fear in female rats. Psychoneuroendocrinology. 2022;141:105776.
doi: 10.1016/j.psyneuen.2022.105776 pubmed: 35489312
Stockhorst U, Antov MI. Modulation of fear extinction by stress, stress hormones and estradiol: a review. Front Behav Neurosci. 2016;9:359.
doi: 10.3389/fnbeh.2015.00359 pubmed: 26858616 pmcid: 4726806
Antov MI, Stockhorst U. Stress exposure prior to fear acquisition interacts with estradiol status to alter recall of fear extinction in humans. Psychoneuroendocrinology. 2014;49:106–18.
doi: 10.1016/j.psyneuen.2014.06.022 pubmed: 25080403
Zeidan MA, Igoe SA, Linnman C, Vitalo A, Levine JB, Klibanski A, et al. Estradiol modulates medial prefrontal cortex and amygdala activity during fear extinction in women and female rats. Biol Psychiatry. 2011;70:920–7.
doi: 10.1016/j.biopsych.2011.05.016 pubmed: 21762880 pmcid: 3197763
Merz CJ, Tabbert K, Schweckendiek J, Klucken T, Vaitl D, Stark R, et al. Neuronal correlates of extinction learning are modulated by sex hormones. Soc Cogn Affect Neurosci. 2012;7:819–30.
doi: 10.1093/scan/nsr063 pubmed: 21990419
Milad MR, Zeidan MA, Contero A, Pitman RK, Klibanski A, Rauch SL, et al. The influence of gonadal hormones on conditioned fear extinction in healthy humans. Neuroscience. 2010;168:652–8.
doi: 10.1016/j.neuroscience.2010.04.030 pubmed: 20412837
White EC, Graham BM. Estradiol levels in women predict skin conductance response but not valence and expectancy ratings in conditioned fear extinction. Neurobiol Learn Mem. 2016;134:339–48.
doi: 10.1016/j.nlm.2016.08.011 pubmed: 27544848
Graham BM, Milad MR. Blockade of estrogen by hormonal contraceptives impairs fear extinction in female rats and women. Biol Psychiatry. 2013;73:371–8.
doi: 10.1016/j.biopsych.2012.09.018 pubmed: 23158459
Felmingham KL, Fong WC, Bryant RA. The impact of progesterone on memory consolidation of threatening images in women. Psychoneuroendocrinology. 2012;37:1896–900.
doi: 10.1016/j.psyneuen.2012.03.026 pubmed: 22534403
van Wingen GA, van Broekhoven F, Verkes RJ, Petersson KM, Bäckström T, Buitelaar JK, et al. Progesterone selectively increases amygdala reactivity in women. Mol Psychiatry. 2008;13:325–33.
doi: 10.1038/sj.mp.4002030 pubmed: 17579609
van Wingen G, van Broekhoven F, Verkes RJ, Petersson KM, Bäckström T, Buitelaar J, et al. How progesterone impairs memory for biologically salient stimuli in healthy young women. J Neurosci. 2007;27:11416–23.
doi: 10.1523/JNEUROSCI.1715-07.2007 pubmed: 17942736 pmcid: 6673029
Hwang MJ, Zsido RG, Song H, Pace-Schott EF, Miller KK, Lebron-Milad K, et al. Contribution of estradiol levels and hormonal contraceptives to sex differences within the fear network during fear conditioning and extinction. BMC Psychiatry. 2015;15:295.
doi: 10.1186/s12888-015-0673-9 pubmed: 26581193 pmcid: 4652367
Lonsdorf TB, Haaker J, Schümann D, Sommer T, Bayer J, Brassen S, et al. Sex differences in conditioned stimulus discrimination during context-dependent fear learning and its retrieval in humans: the role of biological sex, contraceptives and menstrual cycle phases. J Psychiatry Neurosci. 2015;40:368–75.
doi: 10.1503/140336 pubmed: 26107163 pmcid: 4622633
Milad MR, Goldstein JM, Orr SP, Wedig MM, Klibanski A, Pitman RK, et al. Fear conditioning and extinction: influence of sex and menstrual cycle in healthy humans. Behav Neurosci. 2006;120:1196–203.
doi: 10.1037/0735-7044.120.5.1196 pubmed: 17201462
Graham BM, Daher M. Estradiol and progesterone have opposing roles in the regulation of fear extinction in female rats. Neuropsychopharmacology. 2016;41:774–80.
doi: 10.1038/npp.2015.202 pubmed: 26156559
Milad MR, Igoe SA, Lebron-Milad K, Novales JE. Estrous cycle phase and gonadal hormones influence conditioned fear extinction. Neuroscience. 2009;164:887–95.
doi: 10.1016/j.neuroscience.2009.09.011 pubmed: 19761818
Dasharathy SS, Mumford SL, Pollack AZ, Perkins NJ, Mattison DR, Wactawski-Wende J, et al. Menstrual bleeding patterns among regularly menstruating women. Am J Epidemiol. 2012;175:536–45.
doi: 10.1093/aje/kwr356 pubmed: 22350580 pmcid: 3299419
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59:quiz 34–57.
Beck AT, Steer RA, Brown G. Beck Depression Inventory–II (BDI-II) [Database record]. APA PsycTests. 1996. https://doi.org/10.1037/t00742-000 .
Laux L, Glanzmann P, Schaffner P, Spielberger CD. State-trait-angstinventar (STAI). Weinheim: Beltz; 1981.
Ishihara S. Ishihara’s test for colour-blindness. Japan: Kanehara Shuppan Company; 1985.
Milad MR, Wright CI, Orr SP, Pitman RK, Quirk GJ, Rauch SL. Recall of fear extinction in humans activates the ventromedial prefrontal cortex and hippocampus in concert. Biol Psychiatry. 2007;62:446–54.
doi: 10.1016/j.biopsych.2006.10.011 pubmed: 17217927
Kuehl LK, Deuter CE, Hellmann-Regen J, Kaczmarczyk M, Otte C, Wingenfeld K. Enhanced noradrenergic activity by yohimbine and differential fear conditioning in patients with major depression with and without adverse childhood experiences. Prog Neuropsychopharmacol Biol Psychiatry. 2020;96:109751.
doi: 10.1016/j.pnpbp.2019.109751 pubmed: 31446157
Benedek M, Kaernbach C. A continuous measure of phasic electrodermal activity. J Neurosci Methods. 2010;190:80–91.
doi: 10.1016/j.jneumeth.2010.04.028 pubmed: 20451556 pmcid: 2892750
Dawson ME, Schell AM, Filion DL. The electrodermal system. Handbook of psychophysiology. 2007;2:200–23.
van Boxtel A, Boelhouwer AJ, Bos AR. Optimal EMG signal bandwidth and interelectrode distance for the recording of acoustic, electrocutaneous, and photic blink reflexes. Psychophysiology. 1998;35:690–7.
doi: 10.1111/1469-8986.3560690 pubmed: 9844430
Blumenthal TD, Cuthbert BN, Filion DL, Hackley S, Lipp OV, van Boxtel A. Committee report: Guidelines for human startle eyeblink electromyographic studies. Psychophysiology. 2005;42:1–15.
doi: 10.1111/j.1469-8986.2005.00271.x pubmed: 15720576
Bayer J, Gläscher J, Finsterbusch J, Schulte LH, Sommer T. Linear and inverted U-shaped dose-response functions describe estrogen effects on hippocampal activity in young women. Nat Commun. 2018;9:1220.
doi: 10.1038/s41467-018-03679-x pubmed: 29572476 pmcid: 5865215
de Lignieres B, Dennerstein L, Backstrom T. Influence of route of administration on progesterone metabolism. Maturitas. 1995;21:251–7.
doi: 10.1016/0378-5122(94)00882-8 pubmed: 7616875
Brinton RD. Estrogen-induced plasticity from cells to circuits: predictions for cognitive function. Trends Pharmacol Sci. 2009;30:212–22.
doi: 10.1016/j.tips.2008.12.006 pubmed: 19299024 pmcid: 3167490
Sheppard PAS, Koss WA, Frick KM, Choleris E. Rapid actions of oestrogens and their receptors on memory acquisition and consolidation in females. J Neuroendocrinol. 2018;30: https://doi.org/10.1111/jne.12485 .
Taxier LR, Gross KS, Frick KM. Oestradiol as a neuromodulator of learning and memory. Nat Rev Neurosci. 2020;21:535–50.
doi: 10.1038/s41583-020-0362-7 pubmed: 32879508 pmcid: 8302223
Yoest KE, Quigley JA, Becker JB. Rapid effects of ovarian hormones in dorsal striatum and nucleus accumbens. Horm Behav. 2018;104:119–29.
doi: 10.1016/j.yhbeh.2018.04.002 pubmed: 29626485 pmcid: 6197937
Hammoud MZ, Foa EB, Milad MR. Oestradiol, threat conditioning and extinction, post-traumatic stress disorder, and prolonged exposure therapy: a common link. J Neuroendocrinol. 2020;32:e12800.
doi: 10.1111/jne.12800 pubmed: 31595559
Graham BM, Scott E. Effects of systemic estradiol on fear extinction in female rats are dependent on interactions between dose, estrous phase, and endogenous estradiol levels. Horm Behav. 2018;97:67–74.
doi: 10.1016/j.yhbeh.2017.10.009 pubmed: 29079442
Leuchs L, Schneider M, Spoormaker VI. Measuring the conditioned response: a comparison of pupillometry, skin conductance, and startle electromyography. Psychophysiology. 2019;56:e13283.
doi: 10.1111/psyp.13283 pubmed: 30259985

Auteurs

Michael Kaczmarczyk (M)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany. michael.kaczmarczyk@charite.de.
BIH Biomedical Innovation Academy, Berlin Institute of Health (BIH) at Charité-Universitätsmedizin Berlin, Berlin, Germany. michael.kaczmarczyk@charite.de.

Christian Eric Deuter (CE)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Hanna Deus (H)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Anna Kallidou (A)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Christian J Merz (CJ)

Department of Cognitive Psychology, Institute of Cognitive Neuroscience, Faculty of Psychology, Ruhr University Bochum, Bochum, Germany.

Julian Hellmann-Regen (J)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.

Christian Otte (C)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZPG (German Center for Mental Health), partner site Berlin, Berlin, Germany.

Katja Wingenfeld (K)

Department of Psychiatry and Neurosciences, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
DZPG (German Center for Mental Health), partner site Berlin, Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH